KCA encourages all NSW-based child cancer researchers and clinician-researchers to become members.
The aim of KCA membership is to increase the opportunities of members to network and to translate their work into improved clinical outcomes.
There are substantial benefits to membership, including access to funding schemes exclusively available for KCA members. These currently include:
research equipment grants (approx $500k – $1m)
research infrastructure grants (approx $300k x3yr)
research leader grants (approx $750k x5yr)
future research leader grants (approx $250k x5yr)
translational program grants (approx $750k x5yr).
KCA members also have access to other funding streams:
clinical research fellowships (40% of research load x 3yr)
scholar awards (PhD)
clinical education scholarships (further training, mainly for nurses)
project grant funding.
Additional benefits for KCA members include:
the ability to make new collaborative links with pre-clinical and clinical researchers
access to training courses (for clinical fellows)
access to clinical trials, bio-informatics and biostatistical support
access to unique cancer diagnostics, drug discovery, cell and gene therapy, and drug development facilities and expertise
the opportunity to attend regular educational forums